Indicated for patients who are moderately or severely ill with influenza-like illness or at high risk for influenza related complications:
Refer to BCCH oseltamivir algorithm on SHOP
Pre-exposure and post-exposure prophylaxis currently not recommended except in limited cases
Treatment of influenza
Antimicrobial class: Antiviral - neuraminidase inhibitor
Route of Elimination: Hepatically metabolized to >99% of oseltamivir carboxylate (active metabolite) which is eliminated through urine; feces (<20%)